Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Crippa

Showing results (201-210 of 290) with videos related to

Pageof 29
Sort By:
Annals of Surgical Oncology|June 18, 2022
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for CancerGiovanni Guarneri, Diego Palumbo, Nicolò Pecorelli, et al.
Annals of Surgery|February 28, 2009
Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinomaStefan Fritz, Carlos Fernandez-del Castillo, Mari Mino-Kenudson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 23, 2023
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrenceDomenico Tamburrino, Giulio Belfiori, Valentina Andreasi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2023
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapyMarina Macchini, Giulio Belfiori, Stefano Crippa, et al.
Annals of Surgical Oncology|January 24, 2022
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-MakingGiovanni Marchegiani, Stefano Crippa, Giampaolo Perri, et al.
The American Journal of Gastroenterology|March 1, 2017
Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative ManagementStefano Crippa, Raffaele Pezzilli, Massimiliano Bissolati, et al.
Cancers|July 1, 2020
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)Nicola Silvestris, Oronzo Brunetti, Alessandro Bittoni, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Surgery|June 6, 2022
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fireFrancesca Aleotti, Stefano Crippa, Giulio Belfiori, et al.
Surgery|December 30, 2017
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasmsStefano Partelli, Emilio Bertani, Mirco Bartolomei, et al.
Pageof 29

Showing results (201-210 of 290) with videos related to

Sort By:
Pageof 29
Annals of Surgical Oncology|June 18, 2022
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for CancerGiovanni Guarneri, Diego Palumbo, Nicolò Pecorelli, et al.
Annals of Surgery|February 28, 2009
Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinomaStefan Fritz, Carlos Fernandez-del Castillo, Mari Mino-Kenudson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 23, 2023
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrenceDomenico Tamburrino, Giulio Belfiori, Valentina Andreasi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2023
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapyMarina Macchini, Giulio Belfiori, Stefano Crippa, et al.
Annals of Surgical Oncology|January 24, 2022
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-MakingGiovanni Marchegiani, Stefano Crippa, Giampaolo Perri, et al.
The American Journal of Gastroenterology|March 1, 2017
Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative ManagementStefano Crippa, Raffaele Pezzilli, Massimiliano Bissolati, et al.
Cancers|July 1, 2020
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)Nicola Silvestris, Oronzo Brunetti, Alessandro Bittoni, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Surgery|June 6, 2022
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fireFrancesca Aleotti, Stefano Crippa, Giulio Belfiori, et al.
Surgery|December 30, 2017
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasmsStefano Partelli, Emilio Bertani, Mirco Bartolomei, et al.
Pageof 29